Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
Maravai LifeSciences, Inc. (NASDAQ: MRVI) will announce its third quarter 2022 financial and operational results on November 2, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Maravai LifeSciences, Inc. (NASDAQ: MRVI) will announce its third quarter 2022 financial and operational results on November 2, 2022, after market close. The company will also host a conference call at 2:00 PM PT/5:00 PM ET on the same day. Maravai specializes in critical life science products that support drug therapy development, diagnostics, and vaccine innovation. Their solutions are vital for research in human diseases and serve leading biopharmaceutical and gene therapy firms.
Positive
- Leading position in life sciences with a focus on drug therapies, diagnostics, and vaccine development.
Negative
- None.
Details
News Market Reaction – MRVI
The recorded move for MRVI in the trading session of this news was -13.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2022 financial and operating results after the market closes on Wednesday, November 2, 2022, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (877) 315-3037 or (201) 689-8357 and reference Maravai LifeSciences. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
Contact Information:
Media Contact: Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macdougall.bio
Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.